Pancreatic cancer is tough, but we’re taking it on. We’re here for people now, and funding research and campaigning to improve the future.
A diagnosis can be a terrible shock, but we’re here to help make sense of it and guide and support people every step of the way.
From cutting-edge tests to cancer-killing therapies, our scientists are striving for earlier detection and better treatment.
As a leading voice of the pancreatic cancer community, we work with governments, clinicians, researchers and those affected by the disease to find ways to speed up diagnosis, develop faster and better treatments – and call for more investment in research.
Everything you need to provide the best possible care for people with pancreatic cancer.
4 June 2026
Only 12% of people with pancreatic cancer are given the chance to take part in a clinical trial, emphasising the lack of progress in developing treatm...
3 June 2026
Today marks the launch of our Demand Survival Now petition, calling on governments across the UK to fund more research for treatment breakthroughs
31 May 2026
Our comment on daraxonrasib results and the promising group of therapies known as KRAS inhibitors.
4 June 2026
Only 12% of people with pancreatic cancer are given the chance to take part in a clinical trial, emphasising the lack of progress in developing treatm...
3 June 2026
Today marks the launch of our Demand Survival Now petition, calling on governments across the UK to fund more research for treatment breakthroughs
31 May 2026
Our comment on daraxonrasib results and the promising group of therapies known as KRAS inhibitors.
